A61K 33/36
Arsenic
Official title: Arsenic; Compounds thereof
A61K33/36 (Arsenic) appears on 171 US grants and 294 published applications in this corpus.
Search patents in A61K- Granted patents
- 171
- Published applications
- 294
- Assignees
- 165
- Inventors
- 433
- Latest grant
- 8 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 1 | 0 |
| 2000 | 2 | 0 |
| 2001 | 2 | 1 |
| 2002 | 1 | 5 |
| 2003 | 4 | 12 |
| 2004 | 6 | 33 |
| 2005 | 6 | 11 |
| 2006 | 5 | 8 |
| 2007 | 6 | 7 |
| 2008 | 1 | 11 |
| 2009 | 2 | 12 |
| 2010 | 1 | 6 |
| 2011 | 4 | 12 |
| 2012 | 6 | 6 |
| 2013 | 4 | 10 |
| 2014 | 7 | 9 |
| 2015 | 10 | 11 |
| 2016 | 8 | 20 |
| 2017 | 5 | 14 |
| 2018 | 13 | 15 |
| 2019 | 11 | 11 |
| 2020 | 9 | 18 |
| 2021 | 16 | 18 |
| 2022 | 12 | 10 |
| 2023 | 10 | 9 |
| 2024 | 7 | 9 |
| 2025 | 6 | 9 |
| 2026 | 5 | 7 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Inhibitors of the peptidyl-prolyl cis/trans isomerase (PIN1), combinations and uses thereof8 Sep 2026US 12,728,132 B2Beth Israel Deaconess Medical Center, Inc.
- Compounds for use in the treatment of leukemia5 May 2026US 12,616,673 B2Universita' Degli Studi Di Roma “La Sapienza”
- Stable, highly pure L-cysteine compositions for injection and methods of use10 Mar 2026US 12,569,513 B1Exela Pharma Sciences, LLC
- Stable, highly pure L-cysteine compositions for injection and methods of use10 Mar 2026US 12,569,514 B1Exela Pharma Sciences, LLC
- Agent for ameliorating and/or preventing sickle cell disease24 Feb 2026US 12,558,333 B2Neopharma Japan Co., Ltd.
- Reducing systemic regulatory t cell levels or activity for treatment of disease and injury of the cns1 Oct 2026US 2026/0297191 A1ImmunoBrain Checkpoint, Inc.
- Pvax14 nucleic acid in combination with all-trans retinoic acid (atra) and a checkpoint inhibitor for the treatment of cancer17 Sep 2026US 2026/0275342 A1Assistance Publique-Hopitaux de Paris
- Methods for treating aortic valve stenosis with a hedgehog pathway inhibitor10 Sep 2026US 2026/0263396 A1The Trustees of Indiana University
- Pvax14 nucleic acid formulated with nano-vehicle in combination with all-trans retinoic acid (atra) for activating immune pathways13 Aug 2026US 2026/0232777 A1Assistance Publique-Hopitaux de Paris
- Combination therapy for cancer using ros-activated prodrugs and ros-amplifying therapeutics23 Jul 2026US 2026/0207641 A1UWM Research Foundation, Inc.
Most cited
By later US patents
- Topical administration of basic antifungal compositions to treat fungal infections of the nails43US 6,846,837 B22005
- Polyoxometalate materials, metal-containing materials, and methods of use thereof30US 6,723,349 B1Emory University · 2004
- Metal/thiol biocides26US 6,248,371 B1Winthrop University Hospital · 2001
- Compounds for hedgehog pathway blockade in proliferative disorders, including hematopoietic malignancies25US 7,867,492 B2The Board of Trustees of the Leland Stanford Junior University · 2011
- Reducing systemic regulatory T cell levels or activity for treatment of Alzheimer's disease25US 9,512,225 B2Yeda Research and Development Co. Ltd. · 2016